Secondary hyperparathyroidism (SHPT) is a common, serious complication in patients with chronic kidney disease, characterized by increased parathyroid hormone (PTH) levels, parathyroid hyperplasia, and disruptions in bone mineral metabolism [3-5]. Here, PTH is linked to secondary hyperparathyroidism.